The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, New York, United States of America.
Department of Urology, Weill Cornell Medicine, New York, New York, United States of America.
PLoS One. 2019 Jan 4;14(1):e0210079. doi: 10.1371/journal.pone.0210079. eCollection 2019.
Previous studies, including our own, have reported that spermatozoa isolated from the testis have remarkably higher occurrence of aneuploidy once isolated from azoospermic men. This notion, however, did not translate into a lower pregnancy rate nor a greater proportion of miscarriages. Indeed, ICSI offspring generated from surgically retrieved gametes did not suffer from increased karyotypic aneuploidy than children generated from ejaculated specimens. In recent years, aneuploidy assessments on a larger number of cells and utilizing more chromosome probes have reported a progressive decrease in chromosomal aberrations in spermatozoa directly retrieved from the seminiferous tubules. In light of the availability of more accurate molecular genetic techniques, we have decided to challenge the notion that sampling epididymal and testicular tissues yields spermatozoa with higher incidence of aneuploidy than those retrieved in the ejaculate. In a retrospective manner, we have carried out an analysis by FISH with 9 chromosome probes on at least 1000 cells from the ejaculates of 87 consenting men and the specimens of 6 azoospermic men, while spermatozoa of fertile donors were used as control. Aneuploidy by FISH yielded 0.9% for the donor control but rose in the study group to 3.6% in the ejaculated, 1.2% for the epididymal, and 1.1% for testicular spermatozoa. There were no differences in autosomal or gonosomal disomies, nor nullisomies. In this group, once the specimens of these men were used for ICSI, ejaculated spermatozoa yielded a 22% clinical pregnancy rate that resulted in 62.5% pregnancy loss. The surgically retrieved specimens yielded a 50% clinical pregnancy rate that progressed to term. To confirm our findings, in a prospective analysis, DNA sequencing was carried out on the ejaculates and surgical samples of 22 men with various spermatogenic characteristics. In this comparison, the findings were similar with actually a higher incidence of aneuploidy in the ejaculated spermatozoa (n = 16) compared to those surgically retrieved (n = 6) (P<0.0001). For this group, the clinical pregnancy rate for the ejaculated specimens was 47.2% with 29.4% pregnancy loss, while the surgically retrieved yielded a 50% clinical pregnancy rate, all progressing to term. A subsequent prospective combined assessment on ejaculated and surgically retrieved spermatozoa by FISH and NGS was performed on non-azoospermic men with high DNA fragmentation in their ejaculate. The assessment by FISH evidenced 2.8% chromosomal defects in the ejaculated and 1.2% in testicular biopsies while by NGS became 8.4% and 1.3% (P = 0.02), respectively. Interestingly, we evidenced a pregnancy rate of 0% with ejaculated while 100% with the testicular spermatozoa in this latter group. This indicates that improved techniques for assessing sperm aneuploidy on a wider number of cells disproves earlier reports and corroborates the safe utilization of testicular spermatozoa with a positive impact on chances of pregnancy.
先前的研究,包括我们自己的研究,已经报道了从无精子症患者中分离的精子在分离后出现非整倍体的发生率显著升高。然而,这种观点并没有转化为更低的妊娠率或更高的流产率。事实上,通过手术获得的配子生成的 ICSI 后代并没有比通过射出样本生成的后代遭受更高的染色体非整倍体。近年来,对更多数量的细胞进行非整倍体评估,并利用更多的染色体探针,报告了从生精小管中直接获取的精子中的染色体结构异常逐渐减少。鉴于更准确的分子遗传技术的可用性,我们决定挑战从附睾和睾丸组织中采样会产生比射出样本中更高发生率的非整倍体的观点。我们以回顾性的方式,对 87 名同意参与的男性的射出样本和 6 名无精子症男性的样本进行了 9 个染色体探针的 FISH 分析,同时使用了可育供体的精子作为对照。FISH 检测的非整倍体率为供体对照的 0.9%,但在研究组中上升到射出样本的 3.6%、附睾样本的 1.2%和睾丸样本的 1.1%。常染色体或性染色体的三体或单体并没有差异。在这组中,一旦这些男性的样本用于 ICSI,射出的精子的临床妊娠率为 22%,导致 62.5%的妊娠丢失。手术获得的标本的临床妊娠率为 50%,并进展到足月。为了证实我们的发现,在一项前瞻性分析中,对 22 名具有不同生精特征的男性的射出样本和手术样本进行了 DNA 测序。在这项比较中,发现实际上射出的精子中非整倍体的发生率更高(n=16),而手术获得的精子(n=6)(P<0.0001)。对于这组患者,射出样本的临床妊娠率为 47.2%,妊娠丢失率为 29.4%,而手术获得的样本的临床妊娠率为 50%,均进展到足月。随后,对具有高射出样本 DNA 碎片的非无精子症男性进行了射出和手术获得的精子的 FISH 和 NGS 联合前瞻性评估。FISH 评估显示射出样本中有 2.8%的染色体缺陷,睾丸活检中有 1.2%,而 NGS 分别为 8.4%和 1.3%(P=0.02)。有趣的是,我们在后者组中发现射出样本的妊娠率为 0%,而睾丸精子的妊娠率为 100%。这表明,对更多数量的细胞进行非整倍体评估的改进技术否定了早期的报告,并证实了安全利用睾丸精子对提高妊娠机会的积极影响。